Parkinson’s disease (PD) is a well-studied neurodegenerative disorder that affects between 7 and 10 million people worldwide. Despite PD being a recurrent topic in the medical literature for over 200 years, its mechanisms are largely unclear, and existing treatments are aimed at improving the patient’s symptoms.